2010 FDA Warning Letter Findings for Clinical Investigators

IMARC's 2010 warning letter "report card" is in! After reviewing warning letters issued to investigators and sponsor-investigators in 2010 through the FDA's Bioresearch Monitoring Inspection Program, IMARC’s clinical monitoring team has assembled the following "TOP 10" list.